%0 Journal Article %~ PubMed %A Ng, Wy %A Pasutto, F %A Bardakjian, Tm %A Wilson, Mj %A Watson, G %A Schneider, A %A Mackey, DA %A Grigg, Jr %A Zenker, M %A Jamieson, Rv %T A puzzle over several decades: eye anomalies with FRAS1 and STRA6 mutations in the same family. %B Clinical Genetics %D 2013 %C United States %I Wiley-Blackwell Publishing, Inc. %V 83 %N 2 %P 162-168 %@ 1399-0004 %X Ng WY, Pasutto F, Bardakjian TM, Wilson MJ, Watson G, Schneider A, Mackey DA, Grigg JR, Zenker M, Jamieson RV. A puzzle over several decades: eye anomalies with FRAS1 and STRA6 mutations in the same family. Fraser syndrome (FS) and microphthalmia syndromic 9 (MCOPS9) are autosomal recessive conditions with distinct, and some overlapping features affecting the ocular, respiratory and cardiac systems. Mutations in FRAS1 and FREM2 occur in FS, and mutations in STRA6 occur in MCOPS9. We report two sibships, in the same family, where four deceased offspring had ocular, respiratory and cardiac abnormalities. Two sibs with microphthalmia had syndactyly and laryngeal stenosis, suggesting a clinical diagnosis of FS. Our results indicate that they were compound heterozygotes for novel FRAS1 mutations, p.Cys729Phe and p.Leu3813Pro. The other two sibs, first cousins to the first sib pair, had anophthalmia, lung hypoplasia and cardiac anomalies, suggesting a retrospective diagnosis of MCOPS9. Our results indicate compound heterozygous STRA6 mutations, a novel frameshift leading to p.Tyr18* and a p.Thr644Met mutation. The one surviving individual from these sibships is heterozygous for the p.Tyr18*STRA6 mutation and has bilateral ocular colobomata and microphthalmia. This work emphasises the need for careful phenotypic characterisation to determine genes for assessment in ocular syndromic conditions. It also indicates that heterozygous STRA6 mutations may rarely contribute to microphthalmia and coloboma. %Z FOR Codes: 111303 60412 %0 Book Section %A Jamieson, Robyn %A Grigg, John %T Clinical embryology and development of the eye %B Pediatric Ophthalmology and Strabismus 4th Ed %D 2013 %C United Kingdom, USA %I Elsevier Ltd %V %N %P 6-15 %@ 9780702046919 %X %Z FOR Codes: 111301 111401 %0 Book Section %A Grigg, John %A Jamieson, Robyn %T Phakomatoses %B Pediatric Ophthalmology and Strabismus 4th Ed %D 2013 %C United Kingdom, USA %I Elsevier Ltd %V %N %P 675-690 %@ 9780702046919 %X %Z FOR Codes: 111301 111403 %0 Journal Article %~ PubMed %A Souzeau, Emmanuelle %A Goldberg, Ivan %A Healey, Paul R %A Mills, Richard Ad %A Landers, John %A Graham, Stuart L %A Grigg, John Rb %A Usher, Bronwyn %A Straga, Tania %A Crawford, April %A Casson, Robert J %A Morgan, William H %A Ruddle, Jonathan B %A Coote, Michael A %A White, Andrew %A Stewart, James %A Hewitt, Alex W %A Mackey, David A %A Burdon, Kathryn P %A Craig, Jamie E %T Australian and New Zealand Registry of Advanced Glaucoma: methodology and recruitment. %B Clinical and Experimental Ophthalmology %D 2012 %C Australia %I Wiley-Blackwell Publishing Asia %V 40 %N 6 %P 569-575 %@ 1442-9071 %X Background:??? Glaucoma is a sight threatening disease affecting 2-3% of the population over the age of 40. Glaucoma is treatable, and severe vision loss can usually be prevented if diagnosis is made at an early stage. Genetic factors play a major role in the pathogenesis of the condition, and therefore genetic testing to identify asymptomatic at risk individuals is a promising strategy to reduce the prevalence of glaucoma blindness. Furthermore, unravelling genetic risk factors for glaucoma would also allow a better understanding of the pathogenesis of the condition, and the development of new treatments. Design:??? The Australian and New Zealand Registry of Advanced Glaucoma is a prospective study which aims to develop a large cohort of glaucoma cases with severe visual field loss to identify novel genetic risk factors for glaucoma blindness. Methods:??? Clinical information and blood are collected from participants after referral by eye practitioners. Samples are collected across Australia and New Zealand using postage kits. Participants:??? Our registry has recruited just over 2000 participants with advanced glaucoma, as well as secondary and developmental glaucomas. Results:??? A positive family history of glaucoma is present in more than half of the advanced glaucoma cases and the age at diagnosis is significantly younger for participants with affected relatives, which reinforces the involvement of genetic factors in glaucoma. Conclusions:??? With the collection of glaucoma cases recruited so far, our registry aims to identify novel glaucoma genetic risk factors to establish risk profiling of the population and protocols for genetic testing. %Z FOR Codes: 60411 110399 %0 Journal Article %~ PubMed %A Dubey, Rahul %A Birchall, Wayne %A Grigg, John %T Improved Refractive Outcome for Ciliary Sulcus-Implanted Intraocular Lenses. %B Ophthalmology %D 2012 %C United States %I Elsevier Inc. %V 119 %N 2 %P 261-265 %@ 0161-6420 %X To investigate the ideal correction of intraocular lens (IOL) power for sulcus implantation. %Z FOR Codes: 111301 %0 Journal Article %A Chang, John H %A Jang, John D %A Jamieson, Robyn %A Grigg, John %T Long-Term Follow-Up Study of Autosomal Dominant Optic Atrophy in an Australian Population %B Asia-Pacific Journal of Ophthalmology %D 2012 %C United States %I Lippincott Williams & Wilkins %V 1 %N 2 %P 88-90 %@ 2162-0989 %X %Z FOR Codes: 111301 %0 Journal Article %A Dubey, Rahul %A Chan, Kenny %A Lertsumitkul, Somsak %A Grigg, John %A McCluskey, Peter %T Cataract Surgery Outcomes in New South Wales, Australia %B Asian Journal of Ophthalmology %D 2011 %C Netherlands %I Kugler Publications %V 12 %N %P 124-129 %@ 1560-2133 %X %Z FOR Codes: 111301 %0 Journal Article %~ PubMed %A Chen, Celia S %A Lee, Andrew W %A Campbell, Bruce %A Lee, Tien %A Paine, Mark %A Fraser, Clare %A Grigg, John %A Markus, Romesh %T Efficacy of Intravenous Tissue-Type Plasminogen Activator in Central Retinal Artery Occlusion: Report From a Randomized, Controlled Trial. %B Stroke; a journal of cerebral circulation %D 2011 %C United States %I Lippincott Williams & Wilkins %V 42 %N 8 %P 2229-34 %@ 1524-4628 %X Central retinal artery occlusion is caused by a platelet-fibrin thrombus or embolic occlusion and is a stroke of the eye. Observational studies suggest that thrombolytics may restore ocular perfusion and visual function. We hypothesized that intravenous tissue-type plasminogen activator (tPA) administered within 24 hours of symptom onset might restore ocular perfusion and visual function. %Z FOR Codes: 111301 %0 Journal Article %~ PubMed %A Arvind, Hemamalini %A Klistorner, Alexander %A Grigg, John %A Graham, Stuart L %T Low Luminance Contrast Stimulation is Optimal for Early Detection of Glaucoma Using Multifocal Visual Evoked Potentials. %B Investigative ophthalmology & visual science %D 2011 %C United States %I Association for Research in Vision and Ophthalmology %V 52 %N 6 %P 3744-50 %@ 0146-0404 %X The blue-on-yellow multifocal visual evoked potential (BonY mfVEP) stimulus is more sensitive than the conventional black-and-white pattern-reversal stimulus in identifying early glaucoma. BonY employs pattern-onset stimulation and lower luminance contrast (40%) in addition to color. This study was conducted to elucidate the mechanism responsible for the enhanced performance of the BonY stimulus. %Z FOR Codes: 111301 110903 %0 Journal Article %A Fung, Adrian Tien - Chin %A Azar, Domit %A Fraser-Bell, Samantha %A McCluskey, Peter %A Grigg, John %T Ockham's razor revisited: decreased visual acuity secondary to keratoconus in a patient with intracranial hypertension %B BMJ Case Reports %D 2011 %C United Kingdom %I BMJ Group %V 2011 %N %P 0 %@ 1757-790X %X %Z FOR Codes: 111301 %0 Journal Article %~ PubMed %A Fung, Adrian T %A Azar, Domit %A Fraser-Bell, Samantha %A McCluskey, Peter %A Grigg, John %T Ockham's razor revisited: decreased visual acuity secondary to keratoconus in a patient with intracranial hypertension. %B BMJ Case Reports %D 2011 %C United Kingdom %I BMJ Group %V 2011 %N %P bcr0520103030 %@ 1757-790X %X %Z FOR Codes: 111301 %0 Journal Article %~ PubMed %A Chen, Celia S %A Lee, Andrew W %A Campbell, Bruce %A Paine, Mark %A Lee, Tien %A Fraser, Clare %A Grigg, John %A Markus, Romesh %A Williams, Keryn %A Coster, Doug J %T Study of the efficacy of intravenous tissue plasminogen activator in central retinal artery occlusion. %B International Journal of Stroke %D 2011 %C Australia %I Wiley-Blackwell Publishing Asia %V 6 %N 1 %P 87-89 %@ 1747-4949 %X RATIONALE: Central retinal artery occlusion is a stroke of the eye caused by a blockage of its main blood supply by platelet-fibrin clot. Systemic thrombolysis has been successful in restoring perfusion to ischaemic tissue by fibrin-platelet clot lysis in ischaemic stroke and myocardial infarction. Several open-label studies have demonstrated efficacy of thrombolysis in the treatment of central retinal artery occlusion, with up to 60-70% of treated subjects experiencing an improvement in visual acuity. Most of these are given intraarterially, which is an invasive procedure and not widely applicable to all treatment centres. An alternative is the intravenous infusion of tissue plasminogen activator using existing stroke thrombolysis protocols. A systematic review of all observational studies of intravenous tissue plasminogen activator in acute central retinal artery occlusion showed that 48·5% of subjects had a four line or more visual acuity improvement with an acceptable rate of haemorrhagic complications, creating the equipoise necessary to conduct a randomised controlled trial. AIM: To determine the efficacy of intravenous thrombolysis in acute treatment of central retinal artery occlusion. DESIGN: A phase II, placebo-controlled, double-blind, randomised controlled trial comparing intravenous tissue plasminogen activator at 0·9 mg/kg to placebo (normal saline) 100 ml in a 1:1 block randomisation. STUDY OUTCOME: The primary outcome measure is an improvement of three lines or more on the Snellen visual acuity chart, which signifies a doubling of the visual angle. %Z FOR Codes: 110202 110905 %0 Journal Article %~ PubMed %A Grigg, John %A Jang, John D W %A Fung, Adrian T %A Hunyor, Alex P %A Wilson, Trevor %T Trypan Blue to Assess Baerveldt Tube Patency After Repair of Its Obstruction. %B Journal of Glaucoma %D 2011 %C United States %I Lippincott Williams & Wilkins %V 20 %N 9 %P 571-572 %@ 1057-0829 %X Tubal obstruction is a recognized complication of glaucoma drainage implants. In correcting a blocked tube, the surgeon may be uncertain about shunt competence even after removing the suspected cause of obstruction. We report the use of trypan blue dye to show tubal patency directly after the repair of a blocked Baerveldt tube. %Z FOR Codes: 1103 1113 %0 Journal Article %~ PubMed %A Hackett, Anna %A Tarpey, Patrick S %A Licata, Andrea %A Cox, James %A Whibley, Annabel %A Boyle, Jackie %A Rogers, Carolyn %A Grigg, John %A Partington, Michael %A Stevenson, Roger E %A Tolmie, John %A Yates, John Rw %A Turner, Gillian %A Wilson, Meredith %A Futreal, Andrew P %A Corbett, Mark %A Shaw, Marie %A Gecz, Jozef %A Raymond, F Lucy %A Stratton, Michael R %A Schwartz, Charles E %A Abidi, Fatima E %T CASK mutations are frequent in males and cause X-linked nystagmus and variable XLMR phenotypes. %B European journal of human genetics : EJHG %D 2010 %C United Kingdom %I Nature Publishing Group %V 18 %N 5 %P 544-52 %@ 1476-5438 %X Mutations of the calcium/calmodulin-dependent serine protein kinase (CASK) gene have recently been associated with X-linked mental retardation (XLMR) with microcephaly, optic atrophy and brainstem and cerebellar hypoplasia, as well as with an X-linked syndrome having some FG-like features. Our group has recently identified four male probands from 358 probable XLMR families with missense mutations (p.Y268H, p.P396S, p.D710G and p.W919R) in the CASK gene. Congenital nystagmus, a rare and striking feature, was present in two of these families. We screened a further 45 probands with either nystagmus or microcephaly and mental retardation (MR), and identified two further mutations, a missense mutation (p.Y728C) and a splice mutation (c.2521-2A>T) in two small families with nystagmus and MR. Detailed clinical examinations of all six families, including an ophthalmological review in four families, were undertaken to further characterise the phenotype. We report on the clinical features of 24 individuals, mostly male, from six families with CASK mutations. The phenotype was variable, ranging from non-syndromic mild MR to severe MR associated with microcephaly and dysmorphic facial features. Carrier females were variably affected. Congenital nystagmus was found in members of four of the families. Our findings reinforce the CASK gene as a relatively frequent cause of XLMR in females and males. We further define the phenotypic spectrum and demonstrate that affected males with missense mutations or in-frame deletions in CASK are frequently associated with congenital nystagmus and XLMR, a striking feature not previously reported. %Z FOR Codes: 60410 110906 %0 Journal Article %~ PubMed %A Curtin, Jeremy %A Moloney, Greg %A Grigg, John %A Sharota Franzco, Dorian %T Clinical Characterization and Proposed Mechanism of Juvenile Glaucoma-A Patient with a Chromosome 4p Deletion, Wolf-Hirschhorn Syndrome. %B Ophthalmic genetics %D 2010 %C United Kingdom, Cana %I Informa Healthcare %V 31 %N 3 %P 135-8 %@ 1744-5094 %X The case presented is that of a 22-year-old male with Wolf-Hirschhorn syndrome who was referred with glaucoma refractory to medical treatment. Six other patients have been described with Wolf-Hirschhorn syndrome (WHS) and glaucoma, most being congenital glaucoma with diagnosis in infancy. We describe the first case of juvenile onset glaucoma in this syndrome. Our patient had narrow angles on gonioscopy, with ultrasound biomicroscopy revealing ciliary body cysts. We alert others to the possibility of this mechanism of secondary narrow angle glaucoma associated with this chromosomal deletion syndrome. %Z FOR Codes: 111301 %0 Journal Article %~ PubMed %A Habot-Wilner, Zohar %A Sallam, Ahmed %A Roufas, Athena %A Kabasele, Paul Mb %A Grigg, John R %A McCluskey, Peter %A Lightman, Sue %T Periocular corticosteroid injection in the management of uveitis in children. %B Acta ophthalmologica %D 2010 %C United States, Unite %I Wiley-Blackwell Publishing, Inc. %V 88 %N 8 %P e299-304 %@ 1755-3768 %X Acta Ophthalmol. 2010: 88: e299-e304 ABSTRACT.: Purpose:??? To report the outcome of orbital floor corticosteroid injection (OFCI) in the management of uveitis in children. Methods:??? A retrospective noncomparative interventional case series. The medical records of 15 consecutive children (19 eyes) with various forms of uveitis treated with OFCI of 40???mg/ml methylprednisolone acetate or a combination of 20???mg/0.5???ml Triamcinolone and 2???mg/0.5???ml dexamethasone were reviewed. Data were collected 6???months postinjection and included details of uveitis, best corrected visual acuity (BCVA), ocular inflammation, systemic therapy required and potential complications of OFCI. Results:??? The mean BCVA improvement was 0.18 logarithm of the minimum angle of resolution (p???